skip to Main Content

Engineered Bone Marrow Cells Slow Growth of Prostate and Pancreatic Cancer Cells

Newsfeed image, light gray text on dark gray background
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

The results, described January 2020 in the Journal for ImmunoTherapy of Cancer, suggest that the technique — a type of adoptive cell therapy — could target such cancers in humans, using patients’ own marrow cells. Read more . . . 

Back To Top